Rotating sites week to week prevents soreness and lipodystrophy
Diagnosis requires appropriate blood tests and clinical assessment by a GP
Important safety questions include product purity, dose accuracy, drug interactions, liver and kidney considerations, blood sugar changes, cardiovascular risk, pregnancy or breastfeeding status, and long-term exposure
Anti-Doping Agency (USADA) and other sports organizations, and athletes testing positive face penalties.Common Concentration: The 400 mg/mL (or similar 250 mg/mL or 300 mg/mL) concentration is commonly found in illicit markets, intended for performance-enhancing use by bodybuilders and athletes, rather than for veterinary or medical purposes
AHK-Cu may also reduce the secretion of transforming growth factor-beta1 by dermal fibroblasts
Myeloproliferative disorders